Rapaport, FranckSeier, KennethNeelamraju, YaseswiniHassane, DuaneBaslan, TimourGildea, Daniel T.Haddox, SamuelLee, TakMurdock, H. MosesSheridan, CarolineThurmond, AlexisWang, LingCarroll, MartinCripe, Larry D.Fernandez, HugoMason, Christopher E.Paietta, ElisabethRoboz, Gail J.Sun, ZhuoxinTallman, Martin S.Zhang, YanmingGönen, MithatLevine, RossMelnick, Ari M.Kleppe, MariaGarrett-Bakelman, Francine E.2024-06-052024-06-052022-09-23Rapaport F, Seier K, Neelamraju Y, et al. Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999 [published correction appears in Blood Cancer J. 2023 Jul 6;13(1):103]. Blood Cancer J. 2022;12(9):137. Published 2022 Sep 23. doi:10.1038/s41408-022-00736-zhttps://hdl.handle.net/1805/41204en-USAttribution 4.0 InternationalAcute myeloid leukemiaCancer geneticsCytogeneticsIntegrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group's clinical trial E3999Article